Published in Transplantation on December 15, 2006
Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol (2012) 1.21
Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations. Am J Transplant (2009) 0.96
Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. Clin J Am Soc Nephrol (2015) 0.89
Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching. NDT Plus (2010) 0.86
Pregnancy-Induced Sensitization Promotes Sex Disparity in Living Donor Kidney Transplantation. J Am Soc Nephrol (2017) 0.86
Luminex and antibody detection in kidney transplantation. Clin Exp Nephrol (2012) 0.82
Significance of semiquantitative assessment of preformed donor-specific antibody using luminex single bead assay in living related liver transplantation. Clin Dev Immunol (2013) 0.79
Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay. Transfus Med (2009) 0.78
Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: the Northwestern University experience. Transplantation (2008) 0.77
Single antigen flow beads for identification of human leukocyte antigen antibody specificities in hypersensitized patients with chronic renal failure. Cent Eur J Immunol (2016) 0.75
Different impact of pretransplant anti-HLA antibodies detected by Luminex in highly sensitized renal transplanted patients. Biomed Res Int (2013) 0.75
Detection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead Assay. Front Immunol (2016) 0.75
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation (2008) 1.66
Ensuring competency: are fundamentals of laparoscopic surgery training and certification necessary for practicing surgeons and operating room personnel? Surg Endosc (2012) 1.05
A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation (2009) 1.01
African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant (2005) 0.83
Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome. Clin Transplant (2012) 0.80
Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation. Transpl Int (2006) 0.79
Implications of a positive crossmatch in liver transplantation: a 20-year review. Liver Transpl (2012) 0.77
Corticosteroid elimination: the Cincinnati experience. Clin Transpl (2007) 0.77
Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies. Transplantation (2006) 0.77
Efficacy of anticoagulation therapy in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation (2004) 0.77
Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies. Clin Transplant (2006) 0.75